The vaccine business.
Vaccines are expensive and the funding is complex. From Big Pharmaceuticals to public sector, to universities, to NGOs, the UN, non-profit, not-for-profits and huge donations from private foundations, for the drug companies the trail from discovery to delivery requires deep pockets, a clear understa...
Full description
Saved in: